Early studies revealed that high levels of MAF due to the translocation t(14;16)(q32;q23) was seen in 25% of HMCLs, and increased MAF expression was also detected in several t(4;14)-positive myeloma cells with uncertain mechanisms18. This evidence concerns the gene MAF and plasma cell myeloma.